electroCore to Participate at Two Upcoming Investor Conferences

Rhea-AI Summary

electroCore, Inc. (Nasdaq: ECOR) announced participation in two investor conferences. The first is the H.C. Wainwright Global Life Sciences Conference, featuring a pre-recorded fireside chat available from March 9, 2021, at 7:00 a.m. ET. The second is the M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference, starting with a presentation on March 17, 2021, at 9:00 a.m. ET. Both events will include virtual investor meetings and replays will be accessible on the company's website for 90 days.

ROCKAWAY, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that management will participate in two upcoming investor conferences.

H.C. Wainwright Global Life Sciences Conference
Format: pre-recorded fireside chat followed by 1x1 virtual investor meetings
Date: March 9 – 10
The fireside chat will be available for viewing beginning on Tuesday, March 9, 2021 at 7:00 a.m. ET.

Following the conference a webcast replay of the presentation will be available for 90 days on the Investor section of the company’s website, www.electrocore.com

M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference
Format: pre-recorded corporate presentation followed by 1x1 virtual investor meetings
Date: March 17 – 18
The presentation will be available for viewing beginning on Wednesday, March 17, 2021 at 9:00 a.m. ET.

Investors can register for the conference HERE.

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, and the acute and preventive treatment of migraine in adolescent (ages 12 and older) and adult patients.

For more information, visit www.electrocore.com.

Investors:

Hans Vitzthum
LifeSci Advisors
617-430-7578
hans@lifesciadvisors.com

or

Media Contact:

Summer Diaz
electroCore
973-290-0097
summer.diaz@electrocore.com

FAQ

What events is electroCore participating in during March 2021?

electroCore is participating in the H.C. Wainwright Global Life Sciences Conference on March 9-10 and the M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference on March 17-18.

When will the H.C. Wainwright Global Life Sciences Conference presentation be available?

The fireside chat for the H.C. Wainwright Global Life Sciences Conference will be available for viewing starting on March 9, 2021, at 7:00 a.m. ET.

How can I register for the M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference?

Investors can register for the M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference through the link provided in the press release.

What is the current focus of electroCore's bioelectronic medicine?

electroCore focuses on non-invasive vagus nerve stimulation therapy to treat conditions such as cluster headaches and migraines in both adults and adolescents.

Where can I find more information about electroCore's investor presentations?

More information and webcasts of presentations can be found in the Investor section of electroCore's website.